Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Sep. 30, 2012
Assets    
Financing receivables $ 347,871 $ 195,582
Investments 91,964   
Financing receivable and investments held-for-sale 27,971   
Securitization assets 6,144 6,233
Cash and cash equivalents 31,846 20,948
Restricted cash and cash equivalents 49,865 2,035
Intangible assets, net 1,706 2,058
Goodwill 3,798 3,798
Equity method investment in affiliate    787
Other assets 10,267 1,022
Total Assets 571,432 232,463
Liabilities and Equity    
Accounts payable and accrued expenses 7,296 8,419
Deferred funding obligations 74,675  
Credit facility 77,114 4,599
Asset-backed nonrecourse notes (secured by financing receivables of $109.5 million) 100,081  
Other nonrecourse debt (secured by financing receivables of $156.4 million and $195.6 million, respectively) 159,843 200,283
Deferred tax liability 1,799  
Total Liabilities 420,808 213,301
Equity:    
Preferred stock value      
Common stock value 159  
Additional paid in capital 160,120  
Retained (deficit) earnings (13,864) 8,441
Accumulated other comprehensive (loss) income 110 253
Non-controlling interest 4,099  
Total Equity 150,624 19,162
Total Liabilities and Equity 571,432 232,463
Series A Participating Preferred Units [Member]
    
Equity:    
Preferred stock value    10,401
Class A Common Units [Member]
    
Equity:    
Common stock value    $ 67